SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 15.59 |
Enterprise Value ($M) | 33.73 |
Book Value ($M) | -9.97 |
Book Value / Share | -0.22 |
Price / Book | -1.56 |
NCAV ($M) | -34.43 |
NCAV / Share | -0.77 |
Price / NCAV | -0.45 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -4.07 |
Return on Assets (ROA) | -1.31 |
Return on Equity (ROE) | -2.77 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.09 |
Current Ratio | 0.09 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 2.09 |
Assets | 26.56 |
Liabilities | 36.53 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Wong Hing C | 36.04 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
12,802 | 88,396 | 14.48 | |
24,797 | 112,305 | 22.08 | |
5,925 | 89,637 | 6.61 | |
(click for more detail) |
Similar Companies | |
---|---|
FULC – Fulcrum Therapeutics, Inc. | GANX – Gain Therapeutics, Inc. |
GHRS – GH Research PLC | HRMY – Harmony Biosciences Holdings, Inc. |
HROW – Harrow, Inc. |
Financial data and stock pages provided by
Fintel.io